Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Palese

Showing results (171-180 of 291) with videos related to

Pageof 30
Sort By:
Research Square|August 17, 2021
Prophylactic Protection Against Respiratory Viruses Conferred by a Prototype Live Attenuated Influenza Virus VaccineRaveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, et al.
Vaccine|May 26, 2009
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccineSarah A Kopecky-Bromberg, Kathryn A Fraser, Natalie Pica, et al.
Journal of Virology|September 16, 2011
The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B virusesNatalie Pica, Arun Iyer, Irene Ramos, et al.
Plos Pathogens|February 4, 2010
Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccinesBalaji Manicassamy, Rafael A Medina, Rong Hai, et al.
NPJ Vaccines|December 19, 2017
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in miceRaffael Nachbagauer, David Kinzler, Angela Choi, et al.
Frontiers in Immunology|May 21, 2019
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret ModelWen-Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, et al.
Journal of Virology|June 28, 2003
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3Christopher F Basler, Andrea Mikulasova, Luis Martinez-Sobrido, et al.
Journal of Virology|January 5, 2002
Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesisMirella Salvatore, Christopher F Basler, Jean-Patrick Parisien, et al.
Mbio|December 10, 2025
The pandemic gap of respiratory viruses during the COVID-19 pandemicViviana Simon, Daniel Floda, Charles Gleason, et al.
Mbio|March 12, 2015
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in miceTeddy John Wohlbold, Raffael Nachbagauer, Haoming Xu, et al.
Pageof 30

Showing results (171-180 of 291) with videos related to

Sort By:
Pageof 30
Research Square|August 17, 2021
Prophylactic Protection Against Respiratory Viruses Conferred by a Prototype Live Attenuated Influenza Virus VaccineRaveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, et al.
Vaccine|May 26, 2009
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccineSarah A Kopecky-Bromberg, Kathryn A Fraser, Natalie Pica, et al.
Journal of Virology|September 16, 2011
The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B virusesNatalie Pica, Arun Iyer, Irene Ramos, et al.
Plos Pathogens|February 4, 2010
Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccinesBalaji Manicassamy, Rafael A Medina, Rong Hai, et al.
NPJ Vaccines|December 19, 2017
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in miceRaffael Nachbagauer, David Kinzler, Angela Choi, et al.
Frontiers in Immunology|May 21, 2019
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret ModelWen-Chun Liu, Raffael Nachbagauer, Daniel Stadlbauer, et al.
Journal of Virology|June 28, 2003
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3Christopher F Basler, Andrea Mikulasova, Luis Martinez-Sobrido, et al.
Journal of Virology|January 5, 2002
Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesisMirella Salvatore, Christopher F Basler, Jean-Patrick Parisien, et al.
Mbio|December 10, 2025
The pandemic gap of respiratory viruses during the COVID-19 pandemicViviana Simon, Daniel Floda, Charles Gleason, et al.
Mbio|March 12, 2015
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in miceTeddy John Wohlbold, Raffael Nachbagauer, Haoming Xu, et al.
Pageof 30